Mini Review

Published on 14 Aug 2020

An Overview of Acoustic-Based Interventions to Improve Motor Symptoms in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Jessie Siew Pin Leuk
Linette Li Neng Low
Wei-Peng Teo

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00243

12,200 views
15 citations

Original Research

Published on 13 Aug 2020

Distinct Relationship Between Cognitive Flexibility and White Matter Integrity in Individuals at Risk of Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Haidar Alzaid
Thomas Ethofer
Markus A. Hobert
Bernd Kardatzki
Michael Erb
Walter Maetzler
Daniela Berg

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00250

3,962 views
4 citations

Systematic Review

Published on 12 Aug 2020

Gray Matter Alterations in Parkinson's Disease With Rapid Eye Movement Sleep Behavior Disorder: A Meta-Analysis of Voxel-Based Morphometry Studies

in Parkinson’s Disease and Aging-related Movement Disorders

Chengxian Yang
Jianbo Chang
Xiaohang Liang
Xinjie Bao
Renzhi Wang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00213

3,969 views
9 citations

Original Research

Published on 11 Aug 2020

Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

in Parkinson’s Disease and Aging-related Movement Disorders

Valeria Calabrese
Anna Di Maio
Gioia Marino
Antonella Cardinale
Giuseppina Natale
Arianna De Rosa
Federica Campanelli
Maria Mancini
Francesco Napolitano
Luigi Avallone

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00230

6,271 views
20 citations

Original Research

Published on 07 Aug 2020

Transmembrane Protein 230 Mediates a Poly(ADP-ribose) Polymerase-1-Linked Apoptosis

in Parkinson’s Disease and Aging-related Movement Disorders

Xiaobo Wang
Tengteng Wu
Jinru Zhang
Gongbo Guo
XiaoFei He
Zhong Pei
Zhaohui Liu
Chun-feng Liu
Christopher A. Ross
Wanli W. Smith

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00235

3,175 views
8 citations

Original Research

Published on 31 Jul 2020

Clinical and Oculomotor Correlates With Freezing of Gait in a Chinese Cohort of Parkinson’s Disease Patients

in Parkinson’s Disease and Aging-related Movement Disorders

Li Wu
Qin Wang
Lei Zhao
Chun-Yan Jiang
Qian Xu
Si-Cheng Wu
You-Rong Dong
Qing He
Wei Chen
Jian-Ren Liu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00237

3,329 views
9 citations

Original Research

Published on 29 Jul 2020

Study of the Link Between Neuronal Death, Glial Response, and MAPK Pathway in Old Parkinsonian Mice

in Parkinson’s Disease and Aging-related Movement Disorders

Ana Luisa Gil-Martinez
Lorena Cuenca-Bermejo
Pablo Gallo-Soljancic
Consuelo Sanchez-Rodrigo
Virginia Izura
Harry W. M. Steinbusch
Emiliano Fernandez-Villalba
Maria Trinidad Herrero

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00214

2,455 views
5 citations

Original Research

Published on 24 Jul 2020

Lactulose and Melibiose Attenuate MPTP-Induced Parkinson’s Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy

in Parkinson’s Disease and Aging-related Movement Disorders

Chih-Hsin Lin
Pei-Cih Wei
Chiung-Mei Chen
Yu-Ting Huang
Jia-Lan Lin
Yen-Shi Lo
Jia-Li Lin
Chung-Yin Lin
Yih-Ru Wu
Kuo-Hsuan Chang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00226

6,408 views
33 citations

Original Research

Published on 22 Jul 2020

Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Ewa Papuć
Konrad Rejdak

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00156

4,101 views
23 citations

Original Research

Published on 07 Jul 2020

Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Yanmei Chen
Jingxue Zheng
Lufen Su
Fengxian Chen
Ruihan Zhu
Xiaochun Chen
Qinyong Ye

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00210

3,798 views
36 citations

General Commentary

Published on 02 Jul 2020

Response: Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model

in Parkinson’s Disease and Aging-related Movement Disorders

Yan Lin
Leslie A. Sandusky-Beltran
Begona Gamallo-Lana
Adam Mar
Einar M. Sigurdsson

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00205

2,128 views

Original Research

Published on 02 Jul 2020

Structural Covariance Network Disruption and Functional Compensation in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Cheng Zhou
Ting Gao
Tao Guo
Jingjing Wu
Xiaojun Guan
Weiwen Zhou
Peiyu Huang
Min Xuan
Quanquan Gu
Xiaojun Xu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00199

4,731 views
16 citations

Review

Published on 25 Jun 2020

SUMOylation in α-Synuclein Homeostasis and Pathology

in Parkinson’s Disease and Aging-related Movement Disorders

Mor Savyon
Simone Engelender

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00167

6,160 views
25 citations

Review

Published on 19 Jun 2020

Chasing Protection in Parkinson’s Disease: Does Exercise Reduce Risk and Progression?

in Parkinson’s Disease and Aging-related Movement Disorders

Grace F. Crotty
Michael A. Schwarzschild

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00186

22,632 views
48 citations

Original Research

Published on 18 Jun 2020

EEG Slowing and Axial Motor Impairment Are Independent Predictors of Cognitive Worsening in a Three-Year Cohort of Patients With Parkinson's Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Vitalii V. Kozak
Menorca Chaturvedi
Ute Gschwandtner
Florian Hatz
Antonia Meyer
Volker Roth
Peter Fuhr

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00171

2,662 views
2 citations

Perspective

Published on 16 Jun 2020

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism

in Parkinson’s Disease and Aging-related Movement Disorders

Rocco Cerroni
Claudio Liguori
Alessandro Stefani
Matteo Conti
Elena Garasto
Mariangela Pierantozzi
Nicola B. Mercuri
Sergio Bernardini
Giorgio Fucci
Renato Massoud

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00126

3,381 views
7 citations

Navigation group

Articles

An Overview of Acoustic-Based Interventions to Improve Motor Symptoms in Parkinson’s Disease

Distinct Relationship Between Cognitive Flexibility and White Matter Integrity in Individuals at Risk of Parkinson’s Disease

Gray Matter Alterations in Parkinson's Disease With Rapid Eye Movement Sleep Behavior Disorder: A Meta-Analysis of Voxel-Based Morphometry Studies

Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

Transmembrane Protein 230 Mediates a Poly(ADP-ribose) Polymerase-1-Linked Apoptosis

Clinical and Oculomotor Correlates With Freezing of Gait in a Chinese Cohort of Parkinson’s Disease Patients

Study of the Link Between Neuronal Death, Glial Response, and MAPK Pathway in Old Parkinsonian Mice

Lactulose and Melibiose Attenuate MPTP-Induced Parkinson’s Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy

Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson’s Disease

Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson’s Disease

Response: Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model

Structural Covariance Network Disruption and Functional Compensation in Parkinson’s Disease

SUMOylation in α-Synuclein Homeostasis and Pathology

Chasing Protection in Parkinson’s Disease: Does Exercise Reduce Risk and Progression?

EEG Slowing and Axial Motor Impairment Are Independent Predictors of Cognitive Worsening in a Three-Year Cohort of Patients With Parkinson's Disease

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism